Humanin RNR2 (10mg) is a research-grade, lyophilized peptide supplied exclusively for controlled in vitro laboratory research and analytical evaluation. It is not intended for human or animal consumption or for diagnostic, therapeutic, veterinary, food, cosmetic, or dietary supplement use.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Humanin RNR2 (10mg) is a research-grade, mitochondrial-derived peptide supplied as a lyophilized material for controlled in vitro laboratory research and analytical evaluation. Humanin is associated with the mitochondrial MT-RNR2 region and is examined in research involving mitochondrial peptide biology, molecular signaling, peptide identification, and assay development.
This material is supplied exclusively to qualified researchers. It is not intended for human or animal consumption or for diagnostic, therapeutic, veterinary, food, cosmetic, or dietary supplement use.
Humanin RNR2 (10mg) – Research Specifications:
| Product Identity | Humanin RNR2 |
| Quantity | 10mg per vial |
| Compound Type | Mitochondrial-derived research peptide |
| Form | Lyophilized peptide powder |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis for applicable analytical data |
| Analytical Documentation | Batch-specific Certificate of Analysis availability |
| Storage Conditions | Store sealed and protected from heat, light, moisture, and repeated temperature fluctuations |
| Research Classification | For controlled laboratory research and analytical use only |
| Restrictions | Not for human or animal consumption or diagnostic, therapeutic, veterinary, food, cosmetic, or supplement use |
Humanin is a small mitochondrial-derived peptide associated with the MT-RNR2 region of mitochondrial genetic material. It is studied within the broader field of mitochondrial-derived peptide research, which examines molecular communication involving mitochondria and other cellular systems.
Controlled laboratory investigations may use Humanin as an analytical reference or experimental reagent when characterizing peptide identity, molecular interactions, mitochondrial signaling markers, or assay behavior under defined conditions.
Research involving Humanin RNR2 should use appropriate controls, validated analytical methods, documented acceptance criteria, and qualified laboratory personnel. Experimental observations do not establish safety, efficacy, or suitability for any clinical, veterinary, or consumer application.
Important Research Notice: Nordsci research materials are accompanied by lot-specific analytical documentation. Researchers should review the applicable Certificate of Analysis before beginning laboratory work.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED FOR DIAGNOSTIC, THERAPEUTIC, VETERINARY, FOOD, COSMETIC, OR DIETARY SUPPLEMENT USE.
Humanin RNR2 may be incorporated into controlled in vitro models designed to characterize mitochondrial-derived peptide signaling. Laboratory endpoints may include peptide detection, pathway-marker measurement, binding analysis, or comparison against established experimental controls.
Researchers may examine Humanin RNR2 in defined cellular assay systems involving experimentally induced stress conditions. These studies should remain focused on measurable laboratory endpoints and should not be interpreted as evidence of a protective, preventive, or therapeutic effect.
Humanin may be evaluated in laboratory models involving molecular markers associated with metabolic signaling. Appropriate negative controls, positive controls, assay-validation procedures, and predefined analytical criteria should be used when interpreting experimental observations.
Basic laboratory models may include Humanin RNR2 when characterizing age-associated changes in mitochondrial-derived peptide expression or signaling. This research context does not indicate that the material has an anti-aging, longevity, medical, or consumer application.
Humanin RNR2 (10mg) should be handled only by qualified laboratory personnel using appropriate personal protective equipment, contamination controls, documentation practices, and institutional procedures established for research peptides.
Researchers should review the lot-specific Certificate of Analysis and any available safety documentation before opening or handling the vial. Laboratory records should document the product identity, lot number, storage history, preparation date, assay conditions, experimental controls, and analytical results.
Protocol Design Considerations: Experimental concentration, preparation, assay selection, and acceptance criteria must be established through validated laboratory methods and institutional protocols. Nordsci Peptides does not provide dosing, administration, injection, in vivo, veterinary, or consumer-use instructions.
Note: This information is provided exclusively for laboratory research reference. All work must be conducted by qualified personnel in appropriately controlled research facilities.
Each available lot of Humanin RNR2 includes batch-specific analytical documentation for laboratory review. The Certificate of Analysis provides the applicable identity and purity information associated with the tested lot.
Researchers should verify that the product label, lot number, and Certificate of Analysis correspond before beginning analytical or experimental work. COA documentation does not establish approval for human, animal, clinical, diagnostic, or therapeutic use.
Nordsci Peptides supplies Humanin RNR2 (10mg) exclusively as a laboratory research material. Laboratories evaluating a peptide supplier should review product identity, quantity, physical form, storage requirements, lot traceability, analytical documentation, and research-use restrictions before purchasing.
IMPORTANT: Humanin RNR2 (10mg) is sold exclusively for controlled laboratory research and analytical evaluation. It is not for human or animal consumption and may not be used as a drug, treatment, diagnostic material, food, cosmetic, dietary supplement, or veterinary product. Researchers are responsible for complying with all applicable institutional and regulatory requirements.
